Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Olive

Showing results (201-210 of 276) with videos related to

Pageof 28
Sort By:
European Journal of Immunology|September 16, 2011
Differential role for CD277 as a co-regulator of the immune signal in T and NK cellsNassima Messal, Emilie Mamessier, Aude Sylvain, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2016
Butyrophilin 3A/CD277-Dependent Activation of Human γδ T Cells: Accessory Cell Capacity of Distinct Leukocyte PopulationsPatrik Theodor Nerdal, Christian Peters, Hans-Heinrich Oberg, et al.
Experimental Hematology|November 13, 2004
CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantationMohamad Mohty, Sophie Bagattini, Christian Chabannon, et al.
Cell Death & Disease|October 16, 2025
Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killingFrancesca Barberini, Riccardo Pietroni, Simone Ielpo, et al.
Oncoimmunology|November 20, 2019
HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanomaNausicaa Malissen, Nicolas Macagno, Samuel Granjeaud, et al.
Oncoimmunology|May 4, 2016
A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavageColette Dezutter-Dambuyant, Isabelle Durand, Laurent Alberti, et al.
Cell Death & Disease|January 21, 2026
Correction: Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killingFrancesca Barberini, Riccardo Pietroni, Simone Ielpo, et al.
Oncoimmunology|March 5, 2016
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillanceAlessandra Dondero, Fabio Pastorino, Mariella Della Chiesa, et al.
The Journal of Clinical Investigation|August 16, 2011
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunityEmilie Mamessier, Aude Sylvain, Marie-Laure Thibult, et al.
STAR Protocols|October 21, 2022
High-throughput mass cytometry staining for deep phenotyping of human natural killer cellsAmira Ben Amara, Marie-Sarah Rouviere, Stéphane Fattori, et al.
Pageof 28

Showing results (201-210 of 276) with videos related to

Sort By:
Pageof 28
European Journal of Immunology|September 16, 2011
Differential role for CD277 as a co-regulator of the immune signal in T and NK cellsNassima Messal, Emilie Mamessier, Aude Sylvain, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2016
Butyrophilin 3A/CD277-Dependent Activation of Human γδ T Cells: Accessory Cell Capacity of Distinct Leukocyte PopulationsPatrik Theodor Nerdal, Christian Peters, Hans-Heinrich Oberg, et al.
Experimental Hematology|November 13, 2004
CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantationMohamad Mohty, Sophie Bagattini, Christian Chabannon, et al.
Cell Death & Disease|October 16, 2025
Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killingFrancesca Barberini, Riccardo Pietroni, Simone Ielpo, et al.
Oncoimmunology|November 20, 2019
HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanomaNausicaa Malissen, Nicolas Macagno, Samuel Granjeaud, et al.
Oncoimmunology|May 4, 2016
A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavageColette Dezutter-Dambuyant, Isabelle Durand, Laurent Alberti, et al.
Cell Death & Disease|January 21, 2026
Correction: Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killingFrancesca Barberini, Riccardo Pietroni, Simone Ielpo, et al.
Oncoimmunology|March 5, 2016
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillanceAlessandra Dondero, Fabio Pastorino, Mariella Della Chiesa, et al.
The Journal of Clinical Investigation|August 16, 2011
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunityEmilie Mamessier, Aude Sylvain, Marie-Laure Thibult, et al.
STAR Protocols|October 21, 2022
High-throughput mass cytometry staining for deep phenotyping of human natural killer cellsAmira Ben Amara, Marie-Sarah Rouviere, Stéphane Fattori, et al.
Pageof 28